Effect of Phosphatidylserine on Cerebral Glucose Metabolism in Alzheimer's Disease
Notes for this study:
| Effect | Increase |
| Trial Design | Randomized trial |
| Trial Length | 2-4 Weeks |
| Number of Subjects | 8 |
| Sex | Both Genders |
| Age Range | 65+ |
3 weeks supplementation of phosphatidylserine (source not stated, likely bovine cortex based) was able to increase global glucose utilization by 14.8% in the brains of persons with Alzheimer's relative to baseline; this was thought to underlie the benefits observed on symptoms of cognitive decline.
